Company: Cipla Ltd. Category: Company News

Shares of Cipla Ltd fell as much as 3.5 per cent to Rs 500.25 on Thursday morning. The drugmaker posted a 6 per cent jump in June-quarter profit to Rs
Aug. 8, 2019, 12:16 p.m.

The drug maker had set up a separate company with private equity investment in FY2016 to tap the fast growing over the counter medicine portfolio
Aug. 7, 2019, 7:05 p.m.

The company had posted a net profit of ₹445.61 crore in the year-ago period, Cipla said in a filing to BSE.The company received EIR for the Kurkumbh plant for the inspection by the USFDA from March 11-20, 2019, Cipla said
Aug. 7, 2019, 4:32 p.m.

Apart from these firms, Lupin, Aurobindo Pharma, and HPCL will also announce their Q1 results today.
Aug. 7, 2019, 9:41 a.m.

On yoy basis, higher N. American and Indian revenues would aid ~33% yoy EBITDA growth.
Aug. 6, 2019, 4:04 p.m.

In its second deal in about two week weeks, drugmaker Cipla has forged an exclusive partnership with biopharmaceutical company, Alvotech, for the comm
July 29, 2019, 9:02 p.m.

Under the partnership, Alvotech will be responsible for the development and supply of the product, while Cipla Gulf will be responsible for registration and commercialization.
July 29, 2019, 9:10 a.m.

In India, the company said it will focus on therapeutic segments like diabetes, dermatology, cardiology and women's health
July 28, 2019, 11 a.m.

Drug firm Cipla has said its arm Cipla USA Inc has acquired prescription drug Zemdri, used for the treatment of complicated urinary tract infections,
July 25, 2019, 4:36 p.m.

The product is expected to add depth and synergy to its pipeline of specialty products in the US.
July 25, 2019, 8:25 a.m.